cancer of liver and intrahepatic bile duct	is a	malignant neoplasm
cancer of liver and intrahepatic bile duct	originates in	hepatocytes
cancer of liver and intrahepatic bile duct	affects	liver function
hepatitis B	increases risk of	cancer of liver and intrahepatic bile duct
hepatitis C	increases risk of	cancer of liver and intrahepatic bile duct
cirrhosis	increases risk of	cancer of liver and intrahepatic bile duct
alcohol abuse	contributes to	cancer of liver and intrahepatic bile duct
aflatoxin exposure	increases risk of	cancer of liver and intrahepatic bile duct
cancer of liver and intrahepatic bile duct	causes	jaundice
cancer of liver and intrahepatic bile duct	leads to	weight loss
cancer of liver and intrahepatic bile duct	results in	abdominal pain
cancer of liver and intrahepatic bile duct	may cause	ascites
alpha-fetoprotein	is a tumor marker for	cancer of liver and intrahepatic bile duct
ultrasound	detects	cancer of liver and intrahepatic bile duct
CT scan	diagnoses	cancer of liver and intrahepatic bile duct
MRI	evaluates	cancer of liver and intrahepatic bile duct
biopsy	confirms	cancer of liver and intrahepatic bile duct
surgical resection	treats	cancer of liver and intrahepatic bile duct
liver transplantation	treats	cancer of liver and intrahepatic bile duct
radiofrequency ablation	treats	cancer of liver and intrahepatic bile duct
transarterial chemoembolization	treats	cancer of liver and intrahepatic bile duct
sorafenib	targets	cancer of liver and intrahepatic bile duct
lenvatinib	treats	cancer of liver and intrahepatic bile duct
immunotherapy	is used for	cancer of liver and intrahepatic bile duct
radiation therapy	manages	cancer of liver and intrahepatic bile duct
cancer of liver and intrahepatic bile duct	metastasizes to	lungs
cancer of liver and intrahepatic bile duct	spreads to	bones
cancer of liver and intrahepatic bile duct	affects	lymph nodes
portal vein	may be invaded by	cancer of liver and intrahepatic bile duct
hepatic artery	supplies blood to	cancer of liver and intrahepatic bile duct
Child-Pugh score	assesses prognosis of	cancer of liver and intrahepatic bile duct
BCLC staging	classifies	cancer of liver and intrahepatic bile duct
TNM staging	evaluates	cancer of liver and intrahepatic bile duct
cancer of liver and intrahepatic bile duct	has poor	prognosis
early detection	improves outcomes for	cancer of liver and intrahepatic bile duct
surveillance	monitors	cancer of liver and intrahepatic bile duct
chronic liver disease	precedes	cancer of liver and intrahepatic bile duct
non-alcoholic fatty liver disease	increases risk of	cancer of liver and intrahepatic bile duct
hemochromatosis	predisposes to	cancer of liver and intrahepatic bile duct
primary sclerosing cholangitis	associates with	cancer of liver and intrahepatic bile duct
diabetes mellitus	correlates with	cancer of liver and intrahepatic bile duct
obesity	contributes to	cancer of liver and intrahepatic bile duct
smoking	increases risk of	cancer of liver and intrahepatic bile duct
family history	influences risk of	cancer of liver and intrahepatic bile duct
gender	affects incidence of	cancer of liver and intrahepatic bile duct
age	correlates with	cancer of liver and intrahepatic bile duct
viral load	impacts progression of	cancer of liver and intrahepatic bile duct
fibrosis	progresses to	cancer of liver and intrahepatic bile duct
liver enzymes	may elevate in	cancer of liver and intrahepatic bile duct
bilirubin	increases in	cancer of liver and intrahepatic bile duct
albumin	decreases in	cancer of liver and intrahepatic bile duct
prothrombin time	prolongs in	cancer of liver and intrahepatic bile duct
platelet count	reduces in	cancer of liver and intrahepatic bile duct
paraneoplastic syndromes	accompany	cancer of liver and intrahepatic bile duct
hepatic encephalopathy	complicates	cancer of liver and intrahepatic bile duct
variceal bleeding	occurs in	cancer of liver and intrahepatic bile duct
liver failure	results from	cancer of liver and intrahepatic bile duct
palliative care	supports patients with	cancer of liver and intrahepatic bile duct
symptom management	improves quality of life in	cancer of liver and intrahepatic bile duct
nutritional support	benefits patients with	cancer of liver and intrahepatic bile duct
pain management	is essential for	cancer of liver and intrahepatic bile duct
multidisciplinary team	manages	cancer of liver and intrahepatic bile duct
hepatologist	specializes in	cancer of liver and intrahepatic bile duct
oncologist	treats	cancer of liver and intrahepatic bile duct
surgeon	operates on	cancer of liver and intrahepatic bile duct
interventional radiologist	performs procedures for	cancer of liver and intrahepatic bile duct
pathologist	diagnoses	cancer of liver and intrahepatic bile duct
chemotherapy	combats	cancer of liver and intrahepatic bile duct
targeted therapy	inhibits growth of	cancer of liver and intrahepatic bile duct
angiogenesis inhibitors	target	cancer of liver and intrahepatic bile duct
checkpoint inhibitors	activate immunity against	cancer of liver and intrahepatic bile duct
clinical trials	explore new treatments for	cancer of liver and intrahepatic bile duct
personalized medicine	tailors therapy for	cancer of liver and intrahepatic bile duct
liquid biopsy	monitors	cancer of liver and intrahepatic bile duct
genomic profiling	guides treatment of	cancer of liver and intrahepatic bile duct
microenvironment	influences progression of	cancer of liver and intrahepatic bile duct
cancer stem cells	drive growth of	cancer of liver and intrahepatic bile duct
epithelial-mesenchymal transition	promotes metastasis of	cancer of liver and intrahepatic bile duct
Wnt/Î²-catenin pathway	activates	cancer of liver and intrahepatic bile duct
p53 mutation	occurs in	cancer of liver and intrahepatic bile duct
TERT promoter mutation	is common in	cancer of liver and intrahepatic bile duct
CTNNB1 mutation	drives	cancer of liver and intrahepatic bile duct
immune evasion	characterizes	cancer of liver and intrahepatic bile duct
tumor microenvironment	suppresses immunity in	cancer of liver and intrahepatic bile duct
PD-L1 expression	affects response to immunotherapy in	cancer of liver and intrahepatic bile duct
AFP-L3	is a subtype of	alpha-fetoprotein
DCP	is a biomarker for	cancer of liver and intrahepatic bile duct
liquid biopsy	detects circulating tumor DNA in	cancer of liver and intrahepatic bile duct
contrast-enhanced ultrasound	improves detection of	cancer of liver and intrahepatic bile duct
PET scan	evaluates metastasis of	cancer of liver and intrahepatic bile duct
laparoscopy	assesses resectability of	cancer of liver and intrahepatic bile duct
portal vein embolization	prepares for resection of	cancer of liver and intrahepatic bile duct
two-stage hepatectomy	treats advanced	cancer of liver and intrahepatic bile duct
alcohol injection	ablates small	cancer of liver and intrahepatic bile duct
microwave ablation	destroys	cancer of liver and intrahepatic bile duct
yttrium-90 radioembolization	targets	cancer of liver and intrahepatic bile duct
cryoablation	freezes	cancer of liver and intrahepatic bile duct
adjuvant therapy	prevents recurrence of	cancer of liver and intrahepatic bile duct
neoadjuvant therapy	shrinks	cancer of liver and intrahepatic bile duct
survivorship care	follows up	cancer of liver and intrahepatic bile duct
